Upper respiratory tract infection (URI) represents the most common acute illness evaluated in the outpatient setting. URIs range from the common cold—typically a mild, self-limited, catarrhal syndrome of the nasopharynx—to life-threatening illnesses su
(J Respir Dis. 2001;22(7):413-419) As those who treat children are well aware, infections of the upper respiratory tract account for a substantial proportion of pediatric office visits. Of these infections, about one third primarily involve the pharynx. Because of t...
In both studies, the most frequently reported treatment-emergent AEs (≥5% in any treatment group) were acne, cough, headache, herpes zoster, oral herpes, urinary tract infection, upper respiratory tract infection, nasopharyngitis, atopic dermatitis, and elevation in blood creatine phosphokinase level...
Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. In response to the dramatic emergence of resistant pneumococci, more judicious use of antibiotics has been advocated. Physician beliefs, their prescribing ... RL Watson,SF Dowell,M ...
Carefully consider risks and benefits prior to initiating upadacitinib therapy in patients with chronic or recurring infections. Evaluate patients for latent tuberculosis infection prior to and periodically during treatment; if indicated, initiate appropriate antimycobacterial regimen prior to initiating upada...
With appropriate treatment, uncomplicated episodes of Mycoplasma pneumoniae infection can be expected to resolve clinically within 7-10 days after onset. Additional laboratory tests or radiographs usually are not necessary unless the illness fails to respond to therapy, which would raise questions about ...
[three events; reported in three patients], upper respiratory tract infection [three events; reported in three pa- tients], urinary tract infection [three events; reported in three patients], Clostridioides difficile infection [two events; re- ported in two patient...
However, to date no evidence exists on whether managing pre-syncope patients the same as syncope patients improves outcomes. As such, future studies are needed to further explore which patients with pre-syncope are at higher risk for adverse outcomes, with the ultimate goal to derive and ...
AbbVie to Present New Long-term Analysis Evaluating the Sustainability of Response to RINVOQ® (Upadacitinib) Among Patients with Rheumatoid Arthritis
Short ACE2 is substantially upregulated in response to interferon stimulation and rhinovirus infection, but not SARS-CoV-2 infection. This short isoform lacks SARS-CoV-2 spike high-affinity binding sites and, altogether, our data are consistent with a model where short ACE2 is unlikely to ...